The Latest: Pfizer seeks vaccine regulatory review in days
Pfizer announced more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective |!| New London
Pfizer announced more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective |!| New London